The molecular basis of reactive amyloidosis

Shoshana Yakar; Avi Livneh; Batia Kaplan; Mordechai Pras

doi:10.1016/S0049-0172(95)80035-2

The molecular basis of reactive amyloidosis

Shoshana Yakar
, Avi Livneh
, Batia Kaplan
, Mordechai Pras

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

Reactive amyloidosis is a disease occurring in patients suffering from chronicinfections, inflammation, and certain malignant conditions that are characterized by a considerable elevation of the acute phase reactant serum amyloid A (SAA). It is defined by the presence of extracellular deposits of fibrillar material containing amyloid A (AA) as its main component. AA is an 8.5-kd protein structurally identical to the NH₂-terminal of the acute phase reactant SAA. SAA consists of a group of evolutionally conserved amphipathic proteins, encoded by a large number of genes and produced abundantly during inflammation, all suggesting an important role, probably of a neutralizing (anti-inflammatory) nature. An analysis of various aspects of SAA provides no clues to the mechanism of amyloid production, its occurrence in only selected individuals, and its preferential relationship to one isotype of SAA. Until more data is available, the present view on AA amyloidogenesis remains hypothetical.

Original language	English
Pages (from-to)	255-261
Number of pages	7
Journal	Seminars in Arthritis and Rheumatism
Volume	24
Issue number	4
DOIs	https://doi.org/10.1016/S0049-0172(95)80035-2
State	Published - Feb 1995
Externally published	Yes

Keywords

Reactive amyloidosis
amyloid protein A
serum amyloid A

Access to Document

10.1016/S0049-0172(95)80035-2

Cite this

@article{ffbe5569696c4ec08c684a34a11dd669,

title = "The molecular basis of reactive amyloidosis",

abstract = "Reactive amyloidosis is a disease occurring in patients suffering from chronicinfections, inflammation, and certain malignant conditions that are characterized by a considerable elevation of the acute phase reactant serum amyloid A (SAA). It is defined by the presence of extracellular deposits of fibrillar material containing amyloid A (AA) as its main component. AA is an 8.5-kd protein structurally identical to the NH2-terminal of the acute phase reactant SAA. SAA consists of a group of evolutionally conserved amphipathic proteins, encoded by a large number of genes and produced abundantly during inflammation, all suggesting an important role, probably of a neutralizing (anti-inflammatory) nature. An analysis of various aspects of SAA provides no clues to the mechanism of amyloid production, its occurrence in only selected individuals, and its preferential relationship to one isotype of SAA. Until more data is available, the present view on AA amyloidogenesis remains hypothetical.",

keywords = "Reactive amyloidosis, amyloid protein A, serum amyloid A",

author = "Shoshana Yakar and Avi Livneh and Batia Kaplan and Mordechai Pras",

year = "1995",

month = feb,

doi = "10.1016/S0049-0172(95)80035-2",

language = "English",

volume = "24",

pages = "255--261",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - The molecular basis of reactive amyloidosis

AU - Yakar, Shoshana

AU - Livneh, Avi

AU - Kaplan, Batia

AU - Pras, Mordechai

PY - 1995/2

Y1 - 1995/2

N2 - Reactive amyloidosis is a disease occurring in patients suffering from chronicinfections, inflammation, and certain malignant conditions that are characterized by a considerable elevation of the acute phase reactant serum amyloid A (SAA). It is defined by the presence of extracellular deposits of fibrillar material containing amyloid A (AA) as its main component. AA is an 8.5-kd protein structurally identical to the NH2-terminal of the acute phase reactant SAA. SAA consists of a group of evolutionally conserved amphipathic proteins, encoded by a large number of genes and produced abundantly during inflammation, all suggesting an important role, probably of a neutralizing (anti-inflammatory) nature. An analysis of various aspects of SAA provides no clues to the mechanism of amyloid production, its occurrence in only selected individuals, and its preferential relationship to one isotype of SAA. Until more data is available, the present view on AA amyloidogenesis remains hypothetical.

AB - Reactive amyloidosis is a disease occurring in patients suffering from chronicinfections, inflammation, and certain malignant conditions that are characterized by a considerable elevation of the acute phase reactant serum amyloid A (SAA). It is defined by the presence of extracellular deposits of fibrillar material containing amyloid A (AA) as its main component. AA is an 8.5-kd protein structurally identical to the NH2-terminal of the acute phase reactant SAA. SAA consists of a group of evolutionally conserved amphipathic proteins, encoded by a large number of genes and produced abundantly during inflammation, all suggesting an important role, probably of a neutralizing (anti-inflammatory) nature. An analysis of various aspects of SAA provides no clues to the mechanism of amyloid production, its occurrence in only selected individuals, and its preferential relationship to one isotype of SAA. Until more data is available, the present view on AA amyloidogenesis remains hypothetical.

KW - Reactive amyloidosis

KW - amyloid protein A

KW - serum amyloid A

UR - https://www.scopus.com/pages/publications/0028838102

U2 - 10.1016/S0049-0172(95)80035-2

DO - 10.1016/S0049-0172(95)80035-2

M3 - Article

C2 - 7740305

AN - SCOPUS:0028838102

SN - 0049-0172

VL - 24

SP - 255

EP - 261

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

IS - 4

ER -

The molecular basis of reactive amyloidosis

Abstract

Keywords

Access to Document

Fingerprint

Cite this